Skip to main content
Autobound logo
Caris Life Sciences10-Q: Data investment

Increasing 2026 spending on commercial expansion and pipeline trial activities

Read at SEC EDGAR

What happened

The company explicitly plans to increase expenses in 2026 for commercial team expansion and to support a growing number of clinical pipeline trials.

Source

SEC EDGARMay 8, 2026

Quarterly report (Form 10-Q)

Caris Life Sciences 10-Q

Filing excerpt

In 2026, we expect to incur increased expenses related to commercial expansion and increase in pipeline trial activities.

sec.gov/Archives/edgar/data/2019410/000201941026000044/cai-20260331.htmRead the full source

Other signals in this filing (9)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Data investment

What this signalsFilings often name leadership changes, deals and spending plans.

Fiscal year end
03/31
Filed
May 8, 2026

More from Caris Life Sciences

Company page →

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
2019410
Accession number
0002019410-26-000044
Timeframe
Current year
Filing year
2026
Fiscal year
0
Why it matters
Target for data vendors
Signal category
Technology

Extraction

Confidence
High
Relevance
75%
Sentiment
Positive
Detected
May 12, 2026
signal_type
sec-10q
signal_subtype
dataInvestment

Use this data

Get every 10-Q signal for Caris Life Sciences and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Caris Life Sciences this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/82647ea7-1150-4300-81b3-8887b9cd5d38 returns this record as JSON. POST /v1/companies/enrich returns every signal for carislifesciences.com.

{
  "signal_id": "82647ea7-1150-4300-81b3-8887b9cd5d38",
  "signal_type": "sec-10q",
  "signal_subtype": "dataInvestment",
  "detected_at": "2026-05-12T09:24:55.987+00:00",
  "company": {
    "name": "Caris Life Sciences",
    "domain": "carislifesciences.com"
  },
  "data": {
    "detail": "The company explicitly plans to increase expenses in 2026 for commercial team expansion and to support a growing number of clinical pipeline trials. This signals budget for investments in CRM, sales enablement tools, data analytics platforms, and clinical trial management software.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Increasing 2026 spending on commercial expansion and pipeline trial activities",
    "excerpts": "In 2026, we expect to incur increased expenses related to commercial expansion and increase in pipeline trial activities.",
    "relevance": 0.75,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/2019410/000201941026000044/cai-20260331.htm",
    "filing_date": "2026-05-08",
    "filing_year": 2026,
    "fiscal_year": 0,
    "fiscal_year_end": "03/31",
    "sales_relevance": "Target for data vendors",
    "signal_category": "technology"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.